Suppr超能文献

抗生素生物合成中酰胺键形成的一种 ATP 非依赖策略。

An ATP-independent strategy for amide bond formation in antibiotic biosynthesis.

机构信息

Bioengineering Research Group I, Process Technology Research Laboratories, Daiichi Sankyo Co., Ltd., Fukushima, Japan.

出版信息

Nat Chem Biol. 2010 Aug;6(8):581-6. doi: 10.1038/nchembio.393. Epub 2010 Jun 20.

Abstract

A-503083 B, a capuramycin-type antibiotic, contains an L-aminocaprolactam and an unsaturated hexuronic acid that are linked via an amide bond. A putative class C beta-lactamase (CapW) was identified within the biosynthetic gene cluster that-in contrast to the expected beta-lactamase activity-catalyzed an amide-ester exchange reaction to eliminate the L-aminocaprolactam with concomitant generation of a small but significant amount of the glyceryl ester derivative of A-503083 B, suggesting a potential role for an ester intermediate in the biosynthesis of capuramycins. A carboxyl methyltransferase, CapS, was subsequently demonstrated to function as an S-adenosylmethionine-dependent carboxyl methyltransferase to form the methyl ester derivative of A-503083 B. In the presence of free L-aminocaprolactam, CapW efficiently converts the methyl ester to A-503083 B, thereby generating a new amide bond. This ATP-independent amide bond formation using methyl esterification followed by an ester-amide exchange reaction represents an alternative to known strategies of amide bond formation.

摘要

A-503083 B 是一种卡泊芬净类似物抗生素,含有一个 L-氨基己内酰胺和一个不饱和己糖醛酸,通过酰胺键连接。在生物合成基因簇中发现了一种假定的 C 类β-内酰胺酶(CapW),与预期的β-内酰胺酶活性相反,它催化酰胺-酯交换反应,去除 L-氨基己内酰胺,同时生成少量但显著量的 A-503083 B 的甘油酯衍生物,这表明酯中间体能在卡泊芬净的生物合成中发挥作用。随后证明羧甲基转移酶 CapS 作为 S-腺苷甲硫氨酸依赖性羧甲基转移酶,形成 A-503083 B 的甲酯衍生物。在游离 L-氨基己内酰胺存在下,CapW 有效地将甲酯转化为 A-503083 B,从而形成新的酰胺键。这种不依赖于 ATP 的酰胺键形成,使用甲酯化,然后进行酯酰胺交换反应,代表了已知酰胺键形成策略的替代方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验